Etid klinik pou Depresyon nan Oklahoma
11 etid pou Depresyon ap chèche patisipan nan sit nan Oklahoma.
Vil nan Oklahoma
Tèks ofisyèl etid la (Anglè)
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Sooner Clinical Research, Oklahoma City
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407E-Mindfulness Approaches for Living After Breast Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Pahl Pharmaceutical Professionals Llc, Oklahoma City
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Sooner Clinical Research /ID# 226384, Oklahoma City
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Jul 27, 2026 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401Mobile Health Coping Intervention for Mothers Experiencing Food Insecurity
- Oklahoma State University, Stillwater
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07718646A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- University of Oklahoma School of Community Medicine, Tulsa
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
- Laureate Institute for Brain Research, Tulsa
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Apr 20, 2026 · NCT06263660Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
- Laureate Institute for Brain Research, Tulsa
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Oct 31, 2025 · NCT06004115Amplification of Positivity for Alcohol Use
- Laureate Institute for Brain Research, Tulsa
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Jul 18, 2025 · NCT06030154A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.